ABOUT 6th_NIF
> ATTENDEES
> INVESTORS​
> SHOWCASES
> EXHIBITORS
> SPONSORS
> SUPPORTERS

> ABOUT LAST YEAR​

3E Bioventures
5AM Ventures
82VS
AbbVie, Inc.
Accequa AB
Aclipse Therapeutics
Actinogen Medical Ltd.
AcureX Therapeutics
adMare BioInnovations
age1 Fund I GP, LLC
Agile Capital Markets
AGTC Ventures LLC
ALCEDIAG
Alpha Bronze
Alta Global Ventures
Alterity Therapeutics
Alto Neuroscience, Inc.
Amyl Therapeutics
Andera Partners
Angelini Ventures
Aqua Partners LLC
Argobio Studio
Aruna Bio, Inc.
ASDERA LLC
atai Life Sciences N.V.
ATEM Capital
Avestria Ventures
B'IMPRESS - impressive communication
BERNINA BioInvest Ltd.
BioAge Labs, Inc.
BioCentury, Inc.
Biogen
Bionaut Labs
Bioqube Ventures
Bioscience Managers Pty Ltd
BIOSTART Consulting GmbH
BioSymetrics, Inc.
Blackstone Life Sciences
Boehringer Ingelheim International GmbH
Bradley Woods & Co. Ltd.
Braintale
Brandon Capital
BTIG, LLC
Canaccord Genuity LLC
Cantor Fitzgerald
Capital Family Office
Cassel Salpeter & Co., LLC
CBT Advisors
Cenna Biosciences, Inc.
Centre for Aging + Brain Health Innovation (CABHI)
Cerecin Inc.
China Grand Enterprises, Inc.
Class Bravo Ventures
Clexio Biosciences
Cognesy Therapeutics
Cognition Therapeutics, Inc.
Complement Therapeutics Ltd
Consilium Strategic Communications
Cota Capital
Crosswave Management, Inc.
CTI Life Sciences
Cukierman & Co. Investment House Ltd.
Cukierman & Co. Life Sciences
Daiichi Sankyo
David Fox Syndicate
DCVC Bio
Deerfield Management
DEFTA Partners
DigiTx Partners
Dorset Capital LLC
Droia Ventures
Edison Group
EF Hutton
Eight Roads Ventures
Eikonizo Therapeutics, Inc
EIP Pharma, Inc.
Eli Lilly and Company
Emyria
Enveric BioSciences, Inc.
EQT Life Sciences
EryDel SpA
ESP Diagnostics Limited
Evecxia Therapeutics, Inc.
F. Hoffmann-La Roche Ltd.
Ferghana Partners, Inc.
Find Therapeutics Inc.
Forbion
Forty51 Ventures
Fraser Finance LLP
Freedom Capital Markets
FreeMind Group
Fundación de Neurociencias
Gate Neurosciences, Inc.
Gen2 Neuroscience Ltd
Generation Fund Life Sciences Fund I
GeNeuro SA
Gilgamesh Pharmaceuticals
Gimv
Global Emerging Markets (GEM)
Good Health Capital
GreenSky Capital, Inc.
Gryphon Bio, Inc.
H. Lundbeck A/S
H.C. Wainwright & Co.
Hanall Pharmaceutical International Inc.
Hatteras Venture Partners
HBM Partners AG
Health Innovation Capital
HEDA Ventures
Herantis Pharma Plc
Hestia Investments Ltd.
High-Tech Gründerfonds Management GmbH
Hunniwell Lake Ventures LLC
IDG Capital Partners
Ignite Capital Partners, Inc.
Illumina Accelerator
Illumina Ventures
IMMvention Therapeutix, Inc.
Impact India Investment Partners, LLC
Indaco Venture Partners SGR S.p.A.
Independent
InGel Therapeutics, Inc.
Intermediate Capital Group PLC
Inveready Asset Management
Invest Hong Kong
IPF Management S.A.
Ipsen
IRLAB Therapeutics AB
Janssen Research & Development, LLC
JCR Pharmaceuticals
Jeito Capital
JLS Fund LP
Johnson & Johnson Innovation – JJDC, Inc.

Last updated on: 13th of January

Johnson & Johnson Innovation LLC
Johnston Associates
JPMorgan Chase & Co.
JT Pharma
Kaleida Capital
Katan Associates
KeifeRx
Keystone Bio, Inc.
Korys Investments NV
Kures, Inc.
Ladenburg Thalmann & Co. Inc.
Landmark Angels, Inc.
Leaps by Bayer
LikeMinds
Lilly Asia Ventures
LMU Munich
LongeVC
Longevity Biotech, Inc.
Lucia Capital
Lumanity
Lumira Ventures
Lundbeckfonden BioCapital Ventures
M Ventures
Mass General Brigham Ventures
MedTech Strategist
Merck & Co., Inc.
Mid Atlantic Bio Angels
Monument Therapeutics Limited
MUFG Union Bank, N.A.
National Institute of Neurological Disorders and Stroke (NINDS), NIH
National Institute on Aging
Neuraly Inc.
Neuro-Innovators, LLC
Neuromod Devices
NeuroPn Therapeutics
Neuroscience Trials Australia
Neurotech Reports
Neurovascular Research & Design
Neurvati Neurosciences, Inc.
New Harbor Venture Partners, LLC
New Science Global Healthcare Fund
NI Research Inc.
Noble Life Science Partners
Noema Pharma AG
Novartis AG
Novo Holdings
NRx Pharmaceuticals, Inc.
Oceaniq Capital
Oculis SA
OcuTerra Therapeutics
OcuTerra Therapeutics Inc.
Ontario Brain Institute
Ontario Teachers' Pension Plan Board
Oppenheimer & Co. Inc.
Optimum Strategic Communications
OrbiMed Advisors LLC
Oryzon Genomics, S.A.
Osage University Partners
Palo Alto Investors
Panakès Partners SGR SpA
Pangea Botania Ltd
Pappas Capital
Pepper Bio
Perceptive Advisors, LLC
Pharmaphorum Media Limited
PharmaVentures Ltd.
PJT Partners
Praesidia Biotherapeutics, Inc.
Prevail Partners LLC
Primary Peptides Inc.
Pritzker Neuropsychiatric Disorders Research Consortium
Profound Ventures
Prothena Corporation
Protobios
Psilera Inc.
Pureos Bioventures
Qiming Venture Partners
Qynapse, Inc.
Ray Therapeutics, Inc.
Raya Therapeutic
re.Mind Capital Ltd.
Recode Health Ventures
Remiges Ventures, Inc.
ReST THERAPEUTICS
Robeauté
Roth Capital Partners, LLC
Rune Labs, Inc.
RYSE Asset Management
Sand Hill Angels
Sandman Financial
Seventure Partners
Shadow Lake Group Inc.
Silicon Valley Bank
Silicon Valley Ventures
Simcere Pharmaceutical Group
Sixty Degree Capital
Sofinnova Investments, Inc.
Sofinnova Partners
Sony Innovation Fund
Sound Bioventures Management AB
SR One
STALICLA SA
SternAegis Ventures
Stifel Europe
SV Health Investors LLP
Takeda Development Center Americas, Inc.
Talu Ventures
The Benchmark Company, LLC
The Centre for Addiction & Mental Health (CAMH)
The Michael J. Fox Foundation for Parkinson's Research
Theranexus S.A.
TikoMed AB
Torreya
Treo Ventures
TruVenturo GmbH
Twin Oaks Capital, LLC
Unlearn.AI, Inc.
V-Bio Ventures
Valor Management S.A.
Ventac Partners A/S
Venture Valuation
Vine Ventures Real LLC
Vista Capital Advisors, LLC
Viva BioInnovator
WBB Securities, LLC
Wellington Partners
Wells Fargo Bank N.A.
WISE S.r.l.
WPSS.bio
WRF Capital
XOventure GmbH

More TBA...